Patent details

Basic Information

Publication number:

EP2468361

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111947701

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Vildagliptin Formulations

French Title of Invention:

Formulations de vildagliptine

German Title of Invention:

Vildaglitptin-Formulierungen

SPC Number:

Dates

Filing date:

21/12/2011

Grant date:

21/08/2013

EP Publication Date:

21/08/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/06/2012

EP B1 Publication Date:

21/08/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/12/2018

Expiration date:

21/12/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/12/2011

 

 

Name:

Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi

Address:

Istinye Mah. Balabandere Cad. No:14, 34460 Sariyer/Istanbul, Türkiye (TR)

Agent

Name:

MARKS & CLERK LLP

From:

24/10/2013

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Ergenekon Ercan

Address:

Türkiye (TR)

2

Name:

Cifter Ümit

Address:

Türkiye (TR)

3

Name:

Saydam Mehtap

Address:

Türkiye (TR)

4

Name:

Türkyilmaz Ali

Address:

Türkiye (TR)

Priority

Priority Number:

201010683

Priority Date:

21/12/2010

Priority Country:

Türkiye (TR)

Classification

Main IPC Class:

A61P 3/10;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

20/12/2017

Last Annual Fee Paid Number:

7

Last Annual Fee Paid Amount:

82 Euro

Payer:

CPA GLOBAL (PATRAFEE) AB

Filing date	Document type	Number of pages
30/04/2019	Outgoing Correspondence	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56